Journal of General Virology · 1997 · 27 citations · 21 references
Life SciencesInfectious DiseasesMolecular BiologyMolecular VirologyVaccinologyVirologyVaccine PlatformsViral HepatitisViral StructureViral VaccinesVirus StructureVirus-like Particle VaccinesHantavirus VaccinesPurification Of Virus-like ParticlesStop Codon SuppressionViral Antigen RecognitionVirus-like Particle Antigen PresentationVirus-like Particle AssemblyVirus-like Particle EngineeringVirus-like Particles
Because of its particular immunological properties, the core protein of hepatitis B virus (HBcAg) has become one of the favoured 'virus-like particles' for use as a carrier of foreign epitopes. A new strategy to construct core particles presenting extended foreign protein segments was established based on the introduction of a linker containing a translational stop codon between sequences encoding a C-terminally truncated HBcAg (HBcAg delta) and a foreign protein sequence. Expression in an Escherichia coli suppressor strain allowed the simultaneous synthesis of both HBcAg delta and a read-through fusion protein containing a part of the hantavirus nucleocapsid protein. After purification, the presence of core-like mosaic particles with HBc and hantavirus antigenicity was demonstrated by electron microscopy and immunological tests. This strategy of partial stop codon suppression should improve the use of HBcAg as a carrier of foreign epitopes by allowing insertion of long foreign sequences into particle-forming proteins. The resulting mosaic particles should be of general interest for further vaccine developments.
21
Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein
B. E. Clarke, Susan E Newton, Anthony R. Carroll et al. · Nature · 1987 · 333 citations
Andrea Gallina, Fabrizio Bonelli, Lorena Zentilin et al. · Journal of Virology · 1989 · 209 citations · Full text